Personalised treatment of patients with advanced ovarian cancer: comparative analysis of surgical approaches
DOI:
https://doi.org/10.12775/JEHS.2025.83.64576Keywords
ovarian cancer, treatment, cytoreduction, laparoscopy, HIPECAbstract
The authors analysed the results of treatment of patients with advanced ovarian cancer depending on the surgical approach used and the results of NIRES application. The study was conducted at the University Clinic of Odessa National Medical University. The data of 104 patients with advanced ovarian cancer who underwent laparoscopic surgical access (L-CRS) (54 patients) and patients who underwent laparotomy access (O-CRS) (50 patients) were compared. It was shown that laparoscopic access reduced the incidence of postoperative complications of II–IV degrees according to Clavien-Dindo from 56.4% to 27.8% (χ2=14.56; p < 0.001), the duration of hospitalisation (on average (5.4 ± 1.2) days versus (10.1 ± 2.3) days (t = 14.58; p < 0.001) and the time to the start of adjuvant chemotherapy (4.1 ± 1.2) weeks and (7.2 ± 1.5) weeks, respectively (t = 14.29; p < 0.001) without a significant difference in postoperative mortality. The HIPEC technique has demonstrated its clinical safety in the treatment of peritoneal carcinomatosis of various primary localisations.
References
1. Rybin A.I., Demidchik R.YA. Yakistʹ zhyttya khvorykh na rak yayechnykiv pislya provedenoyi tsytoreduktyvnoyi khirurhiyi ta khimioterapiyi // Aktualʹni problemy transportnoyi medytsyny. – 2018. - №4 (54) – S. 59-63. (in Ukrainian)
2. Rybin A.I., Kuznetsova O.V., Maksymovsʹkyy V.YE. Suchasni stratehiyi khirurhichnoho likuvannya khvorykh na tazovyy kantseromatoz, zumovlenyy rakom yayechnykiv // Visnyk morsʹkoyi medytsyny. – 2020. - №2 (87). - S. 55-61. (in Ukrainian)
3. Rybin A. (2022). Rezulʹtaty personifikovanoho likuvannya raku yayechnykiv u khvorykh z kartsynomatozom ocherevyny // Reproduktyvne zdorovʺya zhinky, (7), 35–40. https://doi.org/10.30841/2708-8731.7.2022.272470. (in Ukrainian)
4. Tkachenko O.I., Rybin A.I., Kuznetsova O.V., Maksymovsʹkyy V.YE. Suchasni stratehiyi khirurhichnoho likuvannya khvorykh na rak yayechnyka z tazovym kantseromatozom // Klynycheskaya onkolohyya. – 2018. – Т.8, №3 (31). – S. 1-7. https://repo.odmu.edu.ua:443/xmlui/handle/123456789/7250. (in Ukrainian)
5. Perevahy diahnostychnoyi laparoskopiyi pry poshyrenomu raku yayechnykiv / VH Dubinina, AI Rybin, OV Lukʺyanchuk//Aktualʹni pytannya pediatriyi, akusherstva ta hinekolohiyi.-2012.-№ 1.- S. 114-116. http://nbuv. gov. ua/UJRN/appatg_2012_1_40. (in Ukrainian)
6. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. https://doi.org/10.3322/caac.21492.
7. Bondar O., Rybin A. The experience and results of cytoreductive surgery and HIPEC used in advanced ovarian cancer / ScienceRise. – 2020. - №5. – P. 19-23. https://doi.org/10.21303/2313-8416.2020.001458.
8. Bondar O., Rybin A., Patskov A. The quality of life of ovarian cancer patients as an indication of effectiveness of platinum-based adjuvant chemotherapy // Georgian medical news. – 2021. - №11 (320). – P. 32-36. https://repo.odmu.edu.ua:443/xmlui/handle/123456789/10608.
9. Cortez AJ, Tudre P, Kujawa KA, Lisowska KM. Advances in ovarian cancer therapy. Cancer Chemother Pharmacol. 2018; 81(1): 17–38. doi: 10.1007/s00280-017-3501-8.
10. Oncogynecology / A.I. Rybin and oth.,. – Odessa, ONMedU, 2013. – 200. http://repo.odmu.edu.ua:80/xmlui/handle/123456789/1299
11. Di Vita M, Cappellani A, Piccolo G, Zanghi A, Cavallaro A, Bertola G, et al. The role of HIPEC in the treatment of peritoneal carcinomatosis from gastric cancer: between lights and shadows. Anticancer Drugs. 2015; 26(2):123-138. https://doi.org/10.1097/cad.0000000000000179.
12. Santillan A, Karam AK, Li AJ, Giuntoli R 2nd, Gardner GJ, Cass I, Karlan BY, Bristow RE. Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer. Gynecol Oncol. 2007;104(3):686-690. https://doi.org/10.1016/j.ygyno.2006.10.020.
13. Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221(1):29-42. https://doi.org/10.1097/00000658-199501000-00004.
14. Deraco M, Baratti D, Kusamura S, Laterza B, Balestra MR. Surgical technique of parietal and visceral peritonectomy for peritoneal surface malignancies. J Surg Oncol. 2009;100(4):321-328. https://doi.org/10.1002/jso.21388.
15. Deraco M, Kusamura S, Virzì S, Puccio F, Macrì A, Famulari C, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: Multiinstitutional phase-II trial. Gynecol Oncol. 2011;122(2):215-220. https://doi.org/10.1016/j.ygyno.2011.05.004
16. Deraco M, Virzì S, Iusco D, Puccio F, Macrì A, Famulari C, et al. Secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer: a multi-institutional study. BJOG. 2012;119(7):800-809. https://doi.org/10.1111/j.1471-0528.2011.03207.
17. DiabY,Muallem MZ. Targeted Therapy in Ovarian Cancer. A Comprehensive Systematic Review of Literature. Anticancer Research June 2017, 37 (6) 2809-2815. doi: 10.21873/anticanres.11631.
18. Chandra A, Pius P, Nabeel M, Nair M, Vishwanatha JK. Ovariancancer: Current status and strategies for improving therapeutic outcomes. CancerMed. 2019 Nov; 8(16): 7018–7031. doi: 10.1002/cam4.2560
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 A. Rybin, V. Maksymovskyi, O. Kuznetsova, V. Zamyshlyak
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 97
Number of citations: 0
